Credit Suisse Ag Avanos Medical, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 70,238 shares of AVNS stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,238

Previous 68,819 2.06%

Holding current value

$1.31 Million

Previous $1.54 Million 9.4%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.97 - $22.68 $25,499 - $32,182	1,419 Added 2.06%	70,238 $1.4 Million
Q4 2023 Feb 08, 2024	BUY	$17.64 - $22.99 $161,106 - $209,967	9,133 Added 15.3%	68,819 $1.54 Million
Q3 2023 Nov 13, 2023	SELL	$19.93 - $26.31 $43,885 - $57,934	-2,202 Reduced 3.56%	59,686 $1.21 Million
Q2 2023 Aug 11, 2023	BUY	$22.53 - $30.98 $82,797 - $113,851	3,675 Added 6.31%	61,888 $1.58 Million
Q1 2023 May 10, 2023	BUY	$26.92 - $31.75 $80,006 - $94,361	2,972 Added 5.38%	58,213 $1.73 Million
Q4 2022 Feb 13, 2023	BUY	$19.88 - $27.37 $219,435 - $302,110	11,038 Added 24.97%	55,241 $1.49 Million
Q3 2022 Nov 10, 2022	BUY	$21.56 - $29.59 $9,874 - $13,552	458 Added 1.05%	44,203 $964,000
Q2 2022 Aug 12, 2022	SELL	$24.87 - $34.68 $76,450 - $106,606	-3,074 Reduced 6.57%	43,745 $1.2 Million
Q1 2022 May 16, 2022	SELL	$28.87 - $35.77 $15,445 - $19,136	-535 Reduced 1.13%	46,819 $1.57 Million
Q4 2021 Feb 14, 2022	BUY	$29.25 - $36.02 $76,167 - $93,796	2,604 Added 5.82%	47,354 $1.64 Million
Q3 2021 Nov 12, 2021	SELL	$31.2 - $38.5 $188,510 - $232,617	-6,042 Reduced 11.9%	44,750 $1.4 Million
Q2 2021 Aug 16, 2021	BUY	$36.37 - $45.72 $191,633 - $240,898	5,269 Added 11.57%	50,792 $1.88 Million
Q1 2021 May 14, 2021	SELL	$43.5 - $53.4 $977,401 - $1.2 Million	-22,469 Reduced 33.05%	45,523 $1.99 Million
Q4 2020 Feb 12, 2021	BUY	$33.15 - $49.5 $865,248 - $1.29 Million	26,101 Added 62.31%	67,992 $3.12 Million
Q3 2020 Nov 13, 2020	SELL	$28.67 - $34.32 $85,522 - $102,376	-2,983 Reduced 6.65%	41,891 $1.39 Million
Q2 2020 Aug 12, 2020	BUY	$23.48 - $33.86 $239,449 - $345,304	10,198 Added 29.41%	44,874 $1.32 Million
Q1 2020 May 13, 2020	SELL	$20.64 - $34.41 $67,740 - $112,933	-3,282 Reduced 8.65%	34,676 $933,000
Q4 2019 Feb 12, 2020	SELL	$31.89 - $47.34 $247,849 - $367,926	-7,772 Reduced 17.0%	37,958 $1.28 Million
Q3 2019 Nov 12, 2019	BUY	$32.06 - $44.0 $23,692 - $32,516	739 Added 1.64%	45,730 $1.71 Million
Q2 2019 Aug 14, 2019	SELL	$37.68 - $46.52 $99,588 - $122,952	-2,643 Reduced 5.55%	44,991 $1.96 Million
Q1 2019 May 14, 2019	SELL	$39.84 - $51.04 $524,852 - $672,400	-13,174 Reduced 21.66%	47,634 $2.03 Million
Q4 2018 Feb 13, 2019	SELL	$41.16 - $66.67 $216,707 - $351,017	-5,265 Reduced 7.97%	60,808 $2.72 Million
Q3 2018 Nov 13, 2018	BUY	$55.13 - $72.65 $3.64 Million - $4.8 Million	66,073 New	66,073 $4.53 Million

Others Institutions Holding AVNS

# of Institutions

275

Shares Held

42.5M

Call Options Held

5.4K

Put Options Held

View Full List

About AVANOS MEDICAL, INC.

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $865M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

More about AVNS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account